|
See related Copaxone inj[可舒鬆 注射劑] information |
|
|
|
製造商 |
Teva |
|
代理/經銷商 |
Centapharm |
|
成份 |
Glatiramer acetate |
|
適應症 |
Reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis. |
|
用量 |
Adult 20 mg SC once daily. |
|
美國食品藥物管理局之懷孕等級 |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
注意事項 |
Pre-existing cardiac disorders. Renal impairment. Pregnancy, lactation. |
|
不良反應 |
Inj site reactions: erythema, pain, mass, pruritus, edema, inflammation, hypersensitivity; vasodilatation, chest pain, dyspnoea, palpitation, tachycardia.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
本商品之市售規格 |
|
|
|
Manufacturer: |
Teva |
|
Distributor: |
Centapharm |
|
|
|
|
